$Amazing $Biotech & $olid $Microcap $tocks

[ash111]

BKYI Re-iterates FY 2018 Revenue Guidance Range of $8M - $12M. liabilities cut by 50%, Profit Margin Increased. A very solid ballance sheet ( Total Assets/ Total Liabilities Ratio improved to over 10, which is most solid the sector and probably one of most healthy the Market).
Bio-Key doesn't provide quarterly or semi-year guidance because it's very difficult to predict, so not sure who estimated Q2 revenues or based on what.what's important is that Company Re-iterates FY 2018 Revenue Guidance Range of $8M - $12M.

have read the transcript. talking about their 2 new patents (mentioned IBM..), "we are working on many many oher large retail brick"..such a low MC, impressive reward to me. Just requires a bit of patience… Insiders clearly have it and heavily loaded at a double price.

In fingerprints and banks we trust: IBM reports on the future of authentication https://www.zdnet.com/google-amp/article/in-fingerprints-and-banks-we-trust-ibm-reports-on-the-future-of-authentication/